AEX & Purification. Purification update A reproducible method for VLP purification has been developed which routinely produces material of 80% plus purity.

Slides:



Advertisements
Similar presentations
Protein purification in practice Quantification of the procedure –How well did it work? –Did something go wrong? Where? Know how much fumarase is present.
Advertisements

Sample clean-up (MALDI)
Olotu Ogonah Benjamin Blaha Tarit Mukhopadhyay
BISC 220 Lab 2 Protein Purification by Affinity Chromatography & Determination of Specific Activity.
DNA, Chromosomes By Dr. : Naglaa Mokhtar. DNA Structure.
Plasmid Minipreps Kits….
Industrially Scaleable Process for the Purification and Refolding of Inclusion Body Recombinant Protein BELINDA C. CLARKE 1, GARETH M. FORDE 1, CHARLES.
Immuno-affinity chromatography
Gel filtration Chromatography
Isolation of Plasmid DNA June 21, 2007 Leeward Community College.
Plasmid Isolation RET Summer Overall Picture Plasmid Isolation Remove plasmid pBS 60.6 from DH  E. coli.
Protein Purification and Analysis Solubility of proteins important for purification: 60-80% soluble, 20-40% membrane Size of proteins varies Some proteins.
Developing A Protein Purification Protocol Billie Parker
Workflow of SeMet Protein Preparation Yingyi Fang Haleema Janjua.
Simplicity is the key Continuous purification of monoclonal antibodies L. Landric-Burtin Head of Downstream Processing Development, France Integrated Continuous.
TSB Q7 Meeting 02-Jun-2009 Hepatacore iQur Leeds Progress.
Protein Primary Sequence Protein analysis road map: Bioassay design Isolation/purification Analysis Sequencing.
Proteomics The science of proteomics Applications of proteomics Proteomic methods a. protein purification b. protein sequencing c. mass spectrometry.
C043 iQur Project Update 03 rd Mar Upstream development Three constructs received: –pTAC28b-CoHo7e –pTAC28b-CoHo7SAg,e –pTAC28b-CoHo7e,HAVP1 Plasmids.
Construction of Plasmids & Purification of Core-Haemagglutinin VLPs.
Heterologous Protein Expression in Yeast CoHo7e - Green, Core and HA Malcolm Stratford & Hazel Steels MOLOGIC.
Workflow of the Manual Purification of N/NC5-enriched proteins
1 Workflow Analysis of the Protein Purification Process of SeMet Labeled Proteins September 30, 2005 Haleema Janjua.
The effect of salts and chaperone proteins on Alkaline Phosphatase stability Aka: the results of 271 continuous enzyme activity assays Mary Klein Dhruve.
Protein Purification for Crystallization Dr Muhammad Imran Forman Christian College (A Chartered University) Dr Muhammad Imran Forman Christian College.
FLUTCORE 6M project meeting Pampaloma April, 2016 Olotu Ogonah, Ben Blaha, Tarit Mukhopadhyay.
Lab 6 Ig Purification What will the Ig be used for? How pure does it need to be? What is the source of the antibody (serum, ascites, cell culture supernatant)
Figure 3.1. Chromatogram of L-ficolin elution from the CysNAc column. The relative L-ficolin concentration (closed circles, left Y-axis, arbitrary units)
Protein Overexpression in E. coli and
Tymoczko • Berg • Stryer © 2015 W. H. Freeman and Company
Protein Overexpression in E. coli and
TECHNOLOGY TRANSFER BATCH Flutcore’s meeting 12 th April 2016.
Bioseparation I Centrifugation. What is Bioseparation?  Purification or separation of a specific material of interest from contaminants in a manner that.
Purification Development. Tech-transfer run of VLP 1 performed UCL/iQur with 3P.
Lab Activity 11 Purification of LDH Part II
Lab Activity 12 Purification of LDH Part II
Purification of Green Fluorescent Protein
KM71H pHe7 LAHH3,K1 3P g VLP prep II Bradford assay
Volume 82, Issue 9, Pages (November 2012)
Flutcore meeting 11/4/2016 by Alex Ramirez PhD.
Protein Purification BL
The common lysis solutions contain A. sodium chloride.
Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils
Volume 32, Issue 1, Pages (October 2008)
Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors  Xu Luo, Imawati.
Molecular Therapy - Methods & Clinical Development
BRCA1 Is Associated with a Human SWI/SNF-Related Complex
Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM- stimulated bovine cartilage  M. Durigova, M.Sc., P. Soucy, B.Sc., K. Fushimi,
Brent Berwin, Erik Floor, Thomas F.J Martin  Neuron 
Hsp104, Hsp70, and Hsp40  John R Glover, Susan Lindquist  Cell 
Protein Sample Preparation For NMR Screening
Monitoring the purification
TEV protease elution from cellulose is specific and provides highly purified target protein. TEV protease elution from cellulose is specific and provides.
Volume 7, Issue 11, Pages (November 2000)
Activation of Phosphoinositide 3-Kinase γ by Ras
(a) (b) FhGALE M U I S W1 W2 E1 E2 E3 M - +
The Mammalian Brain rsec6/8 Complex
Molecular Therapy - Methods & Clinical Development
Role of the regulatory domain of the EGF-receptor cytoplasmic tail in selective binding of the clathrin-associated complex AP-2  Werner Boll, Andreas.
Lab Activity 11 Purification of LDH Part II
p53 Protein Exhibits 3′-to-5′ Exonuclease Activity
Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP.
Sharon M Sweitzer, Jenny E Hinshaw  Cell 
Volume 11, Issue 4, Pages (February 2001)
Downstream Processing
Mutual Control of Membrane Fission and Fusion Proteins
Purification of Green Fluorescent Protein
Identification of Regulators of Chaperone-Mediated Autophagy
Epstein–Barr Virus Coopts Lipid Rafts to Block the Signaling and Antigen Transport Functions of the BCR  Michelle L Dykstra, Richard Longnecker, Susan.
Acetylation Regulates Transcription Factor Activity at Multiple Levels
Presentation transcript:

AEX & Purification

Purification update A reproducible method for VLP purification has been developed which routinely produces material of 80% plus purity However, VLP morphology is not homogenous suggesting some large core- containing complexes are formed It is possible that these complexes only form transiently so the time of harvest may need optimisation A final “clean-up” step may be required Sucrose gradients have been used to generate material for in vivo studies but these are not GMP scaleable A combination of SEC and AEX would be ideal but has proven problematic Finally, we need to quantify both purity and morphology on a routine basis and so a matrix of data has been proposed

Optimal harvest time

KM71H pHe7 HA2.3,(M2e) 3 C17-19S.SP UCL fermenter Runs assembly test Samples from UCL of fermenter runs 16 (K1,K1 NB1 Harvest sample only) and 20 (HA2.3,(M2e) 3 C17-19S.SP) Samples 1 pre-induction sample. 3 samples taken over the induction period at various times. 1 Harvested cell paste sample. 2ml each sample run on CL4B XK16/20 in 20mM Tris Ph8.4, 5mM EDTA, 1M Urea

KM71H pHe7 HA2.3,(M2e) 3 C17-19S.SP UCL fermenter Runs assembly test CL4B. 73.5hrsHarvest 75.25hrs K1,K1 Harvest Time hrs 26.9hrs

KM71H pHe7 HA2.3,(M2e) 3 C17-19S.SP UCL fermenter Runs assembly test CL4B. Anti-core blot rHBc (50ng) Marker #13 #4#6 #7 #8#9 #10 #11 #5 #12 rHBc (50ng) Marker #13 #4#6 #7 #8#9 #10 #11 #5 #12 rHBc (50ng) Marker #13 #4#6 #7 #8#9 #10 #11 #5 #12 rHBc (50ng) Marker #13 #4#6 #7 #8#9 #10 #11 #5 #12 rHBc (50ng) Marker #13 #4#6 #7 #8#9 #10 #11 #5 #12 Time hrs 26.9hrs 73.5hrsK1,K1 Harvest rHBc (50ng) Marker #13 #4#6 #7 #8#9 #10 #11 #5 #12 Harvest 75.25hrs 1 min exposure 1 sec exposure1 min exposure VLP

KM71H pHe7 HA2.3,(M2e) 3 C17-19S.SP UCL fermenter Runs assembly test CL4B. Silver stain of peak Void volume fraction (#4) from each run These data suggest that optimal expression is found around 24hrs post- induction This agrees with shake flask fermentation Expression decreases after this time Vaccine candidate yeast can be grown in fermenters

Sucrose gradients

Purification of VLPs from CL4B-S1000 columns by sucrose gradient VLP samples (all from standard CL4B – S1000 column preps) KM71H pHe7 K1,K1, 1.4mg/ml. BL21 coHe7 HA2.3,e, 0.8mg/ml. BL21 coHe7 HA2.9,e, 0.7mg/ml. 0.5ml each loaded onto 10 – 60% sucrose gradients (13ml) in 20mM Tris pH8.4, 5mM EDTA. Centrifugation conditions: Beckman SW40 Ti rotor 30,000 rpm3hrs4 o C RCF (avg) RCF (max) k-Factor ml fractions collected from bottom.

Location of core in gradients by dot and western blot “Goldilocks” VLP region

Summary of results The presence of sucrose, particularly in early samples negatively impacted TEM analysis due to low adherence of proteins to the grids and poor staining. PHe7K1K1 VLPs increased in numbers from fractions 14 to 18. However, the lower numbers of VLPs in the earlier fractions may have been due to higher concentrations of sucrose (up to 4 %) in these diluted samples. Further dilution is unlikely to improve analysis as the resulting concentration of VLPs would be too low for TEM analysis. For the E.coli expressed VLPs, no VLPs were seen in fraction numbers lower than 16. Again, this is most likely due to the high concentration of sucrose in these fractions. BL21 CoHe7HA2.3: Large VLP assemblies were seen in fraction 16 with increasing debris present in later fractions. BL21 CoHe7HA2.9: VLPs were only seen in fraction 18 but these tended to be within aggregates or clumps.

YEAST produced VLPs passed over sucrose gradient post FPLC: SDS-PAGE/Western Blot of fractions. Fractions pooled for each construct and sucrose concentration reduced from ~40% to <1% by dilution and re-concentration on 10kDa cut off spin filters. Fractions of KM71H pHe7 HA2.3,(M2e) 3 C17.19S.SP also pooled and sucrose reduced to <1% in same way. Final concentration and volumes. VLP pool (#): 1.0mg/ml. 1.5ml. Total yield 1.5mg Dirty pool (#):2.3 mg/ml. 1.5ml. Total yield 3.4mg

pHe7 HA2.3,(M2e) 3 C17,19S Sucrose gradient purified VLP Goldilocks VLP regionThree bears VLP region Sucrose cushions can be used to improve the homogeneity of yeast VLP morphology This process is not perfect but should allow in vivo testing to continue

AEX development -AEX polish of SEC purified VLP

KM71H K1,K1 VLP AEX on CIM-DEAE Input run directly through UV detector before loading onto CIM- DEAE All protein bound but nothing eluted by salt gradient or 1M NaOH ml mAU W a s t e ^^ ( C o m p l e t e d ) > E n d _ B l o c k ( I s s u e d ) ( P r o c e s s i n g ) ( C o m p l e t e d ) > E n d _ B l o c k ( I s s u e d ) ( P r o c e s s i n g ) ( C o m p l e t e d ) > E n d _ B l o c k ( I s s u e d ) ( P r o c e s s i n g ) ( C o m p l e t e d ) > E n d _ B l o c k ( I s s u e d ) ( P r o c e s s i n g ) ( C o m p l e t e d ) > Using prep from high copy clone. VLP positive fractions from S1000 (41-50) concentrated to 0.58mg/ml. Run on CIMmultus QA-1 monolith column (1ml column) Buffer A – 20mM Tris pH 8.4, 5mM EDTA Buffer B – 20 mM Tris pH 8.4, 5mM EDTA, 1M NaCl Final wash – 1M NaOH, 1M NaCl 2ml sample loaded Method run (based on column volumes) Column pre-equilibration (5 CV Buffer A) Sample load (2ml) Column wash (5 CV Buffer A) Elution (10 CV 0 – 50% linear gradient Buffer B. Step to 100% Buffer B (10 CV) High salt wash (5 CV 100% Buffer B) Low salt wash (5 CV Buffer A) NaOH wash (5 CV 1M NaOH)

KM71H K1,K1 VLP AEX on CIM-DEAE CIM-DEAE regeneration protocol Wash 1M NaCl, 1M NaOH (20 CV) Hold over night in 1M NaCl, 1M NaOH Wash 1M NaCl, 1M NaOH (10 CV) Wash H 2 O (20 CV) Wash 30% 2-Propanol (20 CV) Wash H 2 O (20 CV) Hold O/N Protein is tightly bound to matrix, only partially released by over-night soak in NaOH. Most seems to be bound by hydrophobic interaction since released by 2- Propanol

KM71H HA2.3,(M2e) 3 C17-19S.SP VLP AEX on CIM-QA Input run directly through UV detector before loading onto CIM- QA All protein bound but only 25% of OD 280 in input eluted by salt gradient or even after 1M NaOH, 1M NaCl. Therefore, protein lost on column. rHBc (50ng) Marker KM71H pHe7 HA2.3,(M2e) 3.SPC1719S High copy clone Fraction 18 Fraction 17 Fraction 16 VLP fractions desalted 1 sec exposure 3 hr exposure

KM71H HA2.3,(M2e) 3 C17-19S.SP VLP AEX on CIM-QA CIM-QA acid wash regeneration protocol 20mM Tris pH 7.0, 5mM EDTA 50% Acetic acid 20mM Tris pH 7.0, 5mM EDTA 50% Acetic acid 20mM Tris pH 7.0, 5mM EDTA Missing protein eluted in 1 st acid wash Although protein levels are low, nucleic acid still appears to be bound to the column

KM71H HA2.3,(M2e) 3 C17-19S.SP VLP AEX on CIM-QA CIM-QA Benzonase regeneration protocol 50mM Tris pH 7.4, 2mM MgCl 2, 0.1M NaCl 200u/ml Benzonase Hold over-night 37 o C (#) 50mM Tris pH 7.4, 2mM MgCl 2, 0.1M NaCl # CIM-QA acid wash regeneration protocol following Benzonase treatment 20mM Tris pH 7.0, 5mM EDTA 50% Acetic acid 20mM Tris pH 7.0, 5mM EDTA 50% Acetic acid 20mM Tris pH 7.0, 5mM EDTA Post Benzonase treatment acid wash elutes protein (small amount) and further nucleic acid

KM71H HA2.3,(M2e) 3 C17-19S.SP VLP AEX on CIM-QA at pH 7.0 Input run directly through UV detector before loading onto CIM-QA Nucleic acid content not significantly reduced by AmS0 4 ppt All protein bound No OD 280 in input eluted by salt gradient VLP precipitated by 40% AmSO 4 in attempt to reduce nucleic acid content

KM71H VLP stability at lower pH Intention to use CIM-DEAE to purify yeast VLPs at lower pH. To allow this SEC purified VLPs (stored in 20mM Tris, 5mM EDTA pH 8.4) were buffer exchanged to 20mM Tris pH 7.0 or 50mM Na-Citrate buffer pH 6.0 using CL-4B (XK16/20). VLPs are expected to elute in void volume. Exchanging K1,K1 to pH 6.0 retains integrity of VLPs as shown by elution in expected region. But Exchanging HA2.3,(M2e)3.C17.19S.SP VLP to pH 6.0 appears to cause VLPs to dissociate to constituent units. Exchanging HA2.3,(M2e)3C17.19S.SP VLP to pH 7.0 appears to be causing an intermediate level of instability. A secondary observation is that Nucleic acid also moves to the small molecule region of the column. This provides further evidence that the nucleic acid present in the VLP region is there due to it being part off or attached to VLPs.

KM71H VLP stability at lower pH K1,K1 pH 8.4 → 6.0 Fractions from Void peak held at pH 6.0 for 72 hrs and then re- run on CL4B Shows that K1,K1 is also unstable at low pH over extended periods

KM71H HA2.3,(M2e) 3 C17-19S.SP VLP AEX on CIM-DEAE pH 7-4 Step Gradient

KM71H HA2.3,(M2e) 3 C17-19S.SP VLP AEX on CIM-DEAE pH 7-4 1M NaCl Step Gradient Core eluted at pH7 1M NaCl is lost on concentration – suggesting aggregation

KM71H HA2.3,(M2e) 3 C17-19S.SP VLP AEX on CIM-DEAE pH 7-4 1M NaCl Step Gradient pH 7 0-1M NaCl gradient Step pH 4 for 5 CV Re-ran pH 7 0-1M NaCl gradient

AEX development -AEX on lysate

Fraction 3 Fraction 4 Fraction 18 Fraction 19 Fraction 16 Fraction 15 rHBc (50ng) Marker Input Fraction 6 Fraction 17 Fraction 20 Note – Only detectable core signal is from fraction at end of sample loading period. Indicating that at this point column had become saturated in ability to bind core. Coomassie stain confirms this for other proteins also. 5 sec exposure 10 min exposure KM71H HA2.3,(M2e) 3 C17-19S.SP VLP lysate without urea. AEX on CIM-DEAE 1M NaCl gradient pH 8.4

KM71H HA2.3,(M2e) 3 C17-19S.SP VLP lysate in 1M urea. AEX on CIM-DEAE 1M NaCl gradient pH 8.4 Fraction 3 Fraction 4 Fraction 19 Fraction 20 Fraction 17 Fraction 16 rHBc (50ng) Marker Input Fraction 6 Fraction 18 Fraction 23 Note – loaded at half total protein load compared to previous sample. No apparent breakthrough of core, coomassie indicates breakthrough of other proteins. Some core signal detected in gradient at ~40% salt (0.4M NaCl) 10 min exposure Fraction 16 Fraction 17 Fraction 17 1M urea Fraction 18 1M urea Fraction 20 Fraction 19 rHBc (50ng) Marker Fraction 15 Fraction 18 Fraction 16 1M urea Fraction 19 1M urea 10 min exposure After concentration (4x), core signal was detectable. Sample without urea treatment eluting over 55 – 88% salt. Some eluting at 100%. Sample with urea treatment eluting at 40%.

KM71H K1,K1 VLP lysate without urea AEX on CIM-DEAE 1M NaCl gradient pH 8.4 Fraction 3 Fraction 4 Fraction 18 Fraction 20 Fraction 16 Fraction 15 rHBc (50ng) Marker Input Fraction 6 Fraction 17 Fraction 23 Significant core in all of flow-through indicating that column has saturated in ability to bind core (possibly higher core content of K1,K1 or lower affinity for DEAE of K1,K1.) Core signal eluting over 20 – 54% salt. At higher salt increase in high molecular weight aggregate seen. 1 sec exposure 10 min exposure

KM71H K1,K1 VLP lysate in 1M urea AEX on CIM-DEAE 1M NaCl gradient pH 8.4 Note – by end of this run back- pressure on had increased to a level at which column can no longer be used Fraction 3 Fraction 4 Fraction 20 Fraction 23 Fraction 17 Fraction 16 rHBc (50ng) Marker Input Fraction 6 Fraction 18 Fraction 24 1 sec exposure 10 min exposure Flow through exhibits strange behaviour, core signal decreasing, this cannot happen on AEX unless material is aggregating and fouling column – decrease in signal corresponds to rapid increase in back-pressure. Core signal eluting between 40 – 60% salt

KM71H pHe7 K1,K1 High Copy Number Clone lysate and lysate after 1M urea loaded onto CIMmultus DEAE AEX fractions desalted and 4 fold concentrated Fraction 16 Fraction 17 Fraction 17 1M urea Fraction 18 1M urea Fraction 23 Fraction 20 rHBc (50ng) Marker Fraction 15 Fraction 18 Fraction 16 1M urea Fraction 20 1M urea K1,K1 binds with lower affinity than HA2.3,(M2e) 3 C17-19S.SP Sample without urea elutes mainly ~ % salt With urea elutes over similar salt range. Urea does not seem to lower affinity of K1,K1 for DEAE 1 sec exposure 10 min exposure

KM71H HA2.3,(M2e) 3 C17-19S.SP and K1,K1 VLP Lysate with and without 1M urea AEX on CIM- DEAE Overall conclusions Both constructs bind DEAE K1,K1 has lower affinity than HA2.3,(M2e) 3 C17-19S.SP Urea treatment of HA2.3,(M2e) 3 C17-19S.SP reduces affinity to similar value as K1,K1 Overall recovery is low for both proteins – large amount of material appears to foul column Urea treated K1,K1 loading of column resulted in complete blockage of column – but it is possible that this was result of cumulative fouling rather than specific to K1,K1.

Is urea necessary for SEC preparation?

KM71H pHe7 HA2.3,(M2e) 3 C17-19S.SP High Copy Clone VLP prep without urea Using High Copy clone (as defined by qPCR). Yeast induced without prior starvation period. 26g cells resuspended in 320ml lysis buffer (20mM Tris pH 8.4, 2mM AEBSF, 5mM DTT, 3000U Benzonase (93u/g)) lysed by pressure homogenisation 500 bar, 3 passes Soluble core extracted from crude lysate with 0.1% Triton X-100 for 1 hr and then centrifuged ~20k x g, 30mins, 4 o C Supernatant (320ml) diluted with 320ml 20mM Tris pH 8.4, 10mM EDTA, to give a final buffer of 20mM Tris pH 8.4, 5mM EDTA. Note – 1M Urea was omitted from this buffer. Vacuum filtered through 0.8µm, 0.45µm and 0.22µm membrane filters Final filtrate washed on 1MDa Pellcon TFF, reducing volume to 25ml. MDa retentate sonicated 2 x 10 sec at 50% power. Then filtered through 0.2µm syringe filter followed by 0.1µm syringe filter (filter washes with SDS buffer after use). Significant back pressure observed on passage through 0.2µm and 0.1µm filter. Stored overnight at 4 o C. Soincated 2 x 10 sec, Then re-filtered (0.2µm). VLPs purified using 2-step Automated AKTAPure program Filtrate applied to Sepharose 4B column (XK26/92) in 20mM Tris pH 8.4, 5mM EDTA, Note – no Urea in this stage. Void volume material ( ml corresponding to fractions 4 – 8 in previous method, 45ml) applied to Sephacryl S1000 column (XK50/92) in 20mM Tris pH 8.4, 5mM EDTA,

KM71H pHe7 HA2.3,(M2e) 3 C17-19S.SP High Copy Clone VLP +/- urea: CL4B comparison to same scale Without urea void region is 70% of + Urea, Small protein regions are equal +/- urea Without urea more large size material is being removed on filters

KM71H pHe7 HA2.3,(M2e) 3 C17-19S.SP High Copy Clone VLP prep without urea: CL4B Void on XK 50/92 S No Urea 1M Urea

KM71H pHe7 HA2.3,(M2e) 3 C17-19S.SP High Copy Clone VLP prep without urea CL4B Void Run on S1000 XK50/92 rHBc (50ng) Marker #70 #38#44 #47 #50#53 #56 #59 #41 #65 rHBc (50ng) Marker #2 (Input) #8 #10 #18 #20 #23 #26 #29 #32 #35 rHBc (50ng) Marker #70 #38#44 #47 #50#53 #56 #59 #41 #65 rHBc (50ng) Marker #2 (Input) #8 #10 #18 #20 #23 #26 #29 #32#35 No Urea 1M Urea Increased degradation in absence of urea

Purification of VLPs from CL4B-S1000 columns by sucrose gradient rHBc (50ng) Marker #26 #7#12 #14 #16#18 #20 #22 #10 #24 rHBc (50ng) Marker #26 #7#12 #14 #16#18 #20 #22 #10 #24 KM71H pHe7 K1,K1 60% 10% KM71H pHe7 HA2.3,(M2e) 3 C17.19S.SP 1M Urea Yield = 0.04mg/g rHBc (50ng) Marker #26 #7#12 #14 #16#18 #20 #22 #10 #24 KM71H pHe7 HA2.3,(M2e) 3 C17.19S.SP No Urea Yield = 0.05mg/g Without Urea more core in ‘Goldilocks’ zone but more degradation – need EMs

Data reporting matrix

KM71H pHe7 HA2.3,M2e Twin High Copy Clone VLP prep Using High Copy (~) clone (as defined by qPCR). Yeast induced without prior starvation period. 26g cells resuspended in 320ml lysis buffer (20mM Tris pH 8.4, 2mM AEBSF, 5mM DTT, 3000U Benzonase (93u/g)) lysed by pressure homogenisation 500 bar, 3 passes Soluble core extracted from crude lysate with 0.1% Triton X-100 for 1 hr and then centrifuged ~20k x g, 30mins, 4 o C Supernatant (480ml) diluted with 320ml 20mM Tris pH 8.4, 10mM EDTA, 2M Urea to give a final buffer of 20mM Tris pH 8.4, 5mM EDTA 1M Urea. Vacuum filtered through 0.8µm, 0.45µm and 0.22µm membrane filters Final filtrate washed on 1MDa Pellicon TFF, reducing volume to 25ml. Unlike other higher copy clones no detectable back pressure detected. Then filtered through 0.2µm syringe filter followed by 0.1µm syringe filter (filter washes with SDS buffer after use). Significant back pressure observed on passage through 0.2µm and 0.1µm filter (2 x 0.1µm units used) Stored overnight at 4 o C. Sonicated 2 x 10 sec, Then re-filtered (0.2µm). VLPs purified using 2-step Automated AKTAPure program Filtrate applied to Sepharose 4B column (XK26/92) in 20mM Tris pH 8.4, 5mM EDTA, 1M Urea. Void volume material ( ml corresponding to fractions 4 – 8 in previous method, 45ml) applied to Sephacryl S1000 column (XK50/92) in 20mM Tris pH 8.4, 5mM EDTA,

KM71H pHe7 HA2.3,M2e Twin High Copy Clone VLP prep 20K s/n 20K pellet Dil s/n 0.1 filtrate Permetate MDa Sonicated CL4B Input 0.1 filter SDS wash MDa 0.2 filtrate rHBc (50ng) Marker Crude lysate 1 sec exposure TFF CL4B

KM71H pHe7 HA2.3,M2e Twin High Copy Clone VLP prep: CL4B Void on XK 50/92 S1000 Fractions pooled and concentrated to 10ml on 1MDa Pellicon. Then to 3ml on 10kDa spin filter. VLP Pool = # , protein concentration 8mg/ml, total yield 24mg VLPVLP VLP

Purification of VLPs from CL4B-S1000 columns by sucrose gradient: SDS-PAGE/Western Blot of fractions. rHBc (50ng) Marker #26 #7#12 #14 #16 #18 #20 #22 #10 #24 60% 10% Fractions pooled and sucrose concentration reduced from ~40% to <1% by dilution and re-concentration on 10kDa cut off spin filters. Final concentration and volumes. VLP pool (#): 0.57mg/ml. 1.5ml. Total yield 0.86mg Dirty pool (#): 0.35mg/ml. 1.5ml. Total yield 0.53mg

Biochemistry summary data ParameterValueUnits Volume of culture1.8L Wet weight pellet26g Band visible on initial gel?Y(Y/N) TFFy = x -0.5 R² = Equation AUC (S1000 fractions)27.5mAu*ml Purity (image analysis)20% Amount recovered24mg Yield0.09% Purity sucrose (image analysis)20% Amount recovered sucrose0.86mg Yield sucrose0.003% EM (image analysis)% VLP

Image analysis S1000 Sucrose TC Total % purity18.8%15.3%12.1%24.1%25.7%19.2% TC Total % Purity20.5%20.8%20.5%17.3%19.8%